Biohaven (BHVN) Earnings Date & Reports

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

BHVN is expected to report earnings to -170 cents per share on May 09

Q1'25

Est.

$-1.70

Q4'24

Missed

by $0.11

Q3'24

Missed

by $0.04

Q2'24

Missed

by $1.72

Q1'24

Missed

by $0.65

The last earnings report on March 03 showed earnings per share of -171 cents, missing the estimate of -160 cents. With 2.68M shares outstanding, the current market capitalization sits at 2.10B.

View a ticker or compare two or three

Compare

BHVN